Healthcare provider profile · identity verified

Sarim Idrees, M.D.

Internal Medicine · LAKELAND, FL · NPI 1144617382

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	663	218
Lisinopril	Lisinopril	432	129
Losartan Potassium	Losartan Potassium	379	122
Gabapentin	Gabapentin	356	127
Tramadol Hcl	Tramadol Hcl	331	80
Albuterol Sulfate Hfa	Albuterol Sulfate	301	91
Pantoprazole Sodium	Pantoprazole Sodium	296	102
Omeprazole	Omeprazole	291	105
Levothyroxine Sodium	Levothyroxine Sodium	284	83
Amlodipine Besylate	Amlodipine Besylate	264	92
Fluticasone Propionate	Fluticasone Propionate	253	106
Alprazolam	Alprazolam	252	51
Carvedilol	Carvedilol	252	77
Furosemide	Furosemide	250	88
Rosuvastatin Calcium	Rosuvastatin Calcium	233	81
Montelukast Sodium	Montelukast Sodium	232	90
Meloxicam	Meloxicam	220	93
Trazodone Hcl	Trazodone Hcl	220	81
Tizanidine Hcl	Tizanidine Hcl	218	96
Jardiance	Empagliflozin	201	44
Prednisone	Prednisone	190	101
Metformin Hcl	Metformin Hcl	180	73
Metoprolol Tartrate	Metoprolol Tartrate	168	56
Glipizide	Glipizide	166	52
Tamsulosin Hcl	Tamsulosin Hcl	166	59
Metoprolol Succinate	Metoprolol Succinate	157	62
Hydrochlorothiazide	Hydrochlorothiazide	149	55
Sertraline Hcl	Sertraline Hcl	149	52
Simvastatin	Simvastatin	149	44
Famotidine	Famotidine	131	44
Ozempic	Semaglutide	113	25
Amoxicillin	Amoxicillin	109	81
Ibuprofen	Ibuprofen	104	48
Clopidogrel	Clopidogrel Bisulfate	100	29
Januvia	Sitagliptin Phosphate	100	18
Eliquis	Apixaban	98	23
Hydralazine Hcl	Hydralazine Hcl	95	36
Pravastatin Sodium	Pravastatin Sodium	94	31
Ciprofloxacin Hcl	Ciprofloxacin Hcl	86	61
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	85	35
Duloxetine Hcl	Duloxetine Hcl	82	22
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	80	36
Hydroxyzine Hcl	Hydroxyzine Hcl	79	33
Doxycycline Monohydrate	Doxycycline Monohydrate	76	50
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	71	20
Pregabalin	Pregabalin	69	20
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	68	46
Oxybutynin Chloride Er	Oxybutynin Chloride	67	20
Azithromycin	Azithromycin	63	56
Fluconazole	Fluconazole	63	40
Isosorbide Mononitrate Er	Isosorbide Mononitrate	62	18
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	61	12
Ondansetron Hcl	Ondansetron Hcl	61	32
Allopurinol	Allopurinol	59	24
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	58	44
Testosterone Cypionate	Testosterone Cypionate	57	12
Alendronate Sodium	Alendronate Sodium	56	20
Potassium Chloride	Potassium Chloride	56	24
Clonidine Hcl	Clonidine Hcl	55	15
Ezetimibe	Ezetimibe	54	19
Sildenafil Citrate	Sildenafil Citrate	52	18
Meclizine Hcl	Meclizine Hcl	51	31
Clonazepam	Clonazepam	46	16
Dicyclomine Hcl	Dicyclomine Hcl	46	24
Atenolol	Atenolol	45	11
Metformin Hcl Er	Metformin Hcl	45	23
Mirtazapine	Mirtazapine	45	16
Baclofen	Baclofen	43	23
Lorazepam	Lorazepam	43	11
Oxybutynin Chloride	Oxybutynin Chloride	43	11
Finasteride	Finasteride	40	15
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	40	16
Citalopram Hbr	Citalopram Hydrobromide	37	15
Topiramate	Topiramate	35	11
Quetiapine Fumarate	Quetiapine Fumarate	34	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	33	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	32	14
Escitalopram Oxalate	Escitalopram Oxalate	31	suppressed
Lactulose	Lactulose	31	14
Primidone	Primidone	31	suppressed
Propranolol Hcl	Propranolol Hcl	31	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	30	12
Nifedipine Er	Nifedipine	30	13
Diclofenac Sodium	Diclofenac Sodium	29	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	29	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	28	21
Naproxen	Naproxen	28	suppressed
Ropinirole Hcl	Ropinirole Hcl	28	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	28	11
Donepezil Hcl	Donepezil Hcl	27	11
Fenofibrate	Fenofibrate	26	12
Insulin Syringe	Syringe And Needle,insulin,1ml	26	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	26	suppressed
Warfarin Sodium	Warfarin Sodium	26	suppressed
Spironolactone	Spironolactone	25	12
Triamcinolone Acetonide	Triamcinolone Acetonide	25	20
Buspirone Hcl	Buspirone Hcl	24	suppressed
Ciclopirox	Ciclopirox	23	suppressed
Xarelto	Rivaroxaban	23	suppressed
Acyclovir	Acyclovir	22	suppressed
Bupropion Hcl	Bupropion Hcl	22	suppressed
Celecoxib	Celecoxib	22	suppressed
Symbicort	Budesonide/Formoterol Fumarate	22	suppressed
Glimepiride	Glimepiride	21	suppressed
Lovastatin	Lovastatin	21	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	21	suppressed
Nitroglycerin	Nitroglycerin	21	11
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	21	suppressed
Levofloxacin	Levofloxacin	20	20
Paxlovid	Nirmatrelvir/Ritonavir	19	19
Telmisartan	Telmisartan	19	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	18	11
Olmesartan Medoxomil	Olmesartan Medoxomil	18	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	17	suppressed
Amiodarone Hcl	Amiodarone Hcl	17	suppressed
Humalog Mix 75-25	Insulin Lispro Protamin/Lispro	17	suppressed
Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	17	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Ketoconazole	Ketoconazole	16	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Memantine Hcl	Memantine Hcl	16	suppressed
Nystatin	Nystatin	16	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	15	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	15	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	15	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	14	suppressed
Benzonatate	Benzonatate	14	11
Entresto	Sacubitril/Valsartan	14	suppressed
Glipizide Er	Glipizide	14	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Insulin Syringe	Syring-Needl,disp,insul,0.3 Ml	13	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Brilinta	Ticagrelor	12	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Bupropion Xl	Bupropion Hcl	12	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	12	suppressed
Gentamicin Sulfate	Gentamicin Sulfate	12	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	12	suppressed
Promethazine Hcl	Promethazine Hcl	12	suppressed
Trulicity	Dulaglutide	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Anastrozole	Anastrozole	11	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Breyna	Budesonide/Formoterol Fumarate	11	suppressed
Folic Acid	Folic Acid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error